WHO says booster shots outstrip science, blind to vaccine inequity

The U.S. authorises third Pfizer dose, Thailand reduces quarantine

USA regulators have authorised a booster dose of Pfizer Inc.’s Covid-19 vaccine for people aged 65 and over

The growing interest in administering booster doses over waning immunity from full COVID-19 vaccinations could be a decision moving ahead of the science of vaccines, the World Health Organisation (WHO) has cautioned. The move also marks a loss of touch with the current realities of inequitable va

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```